文献速递流行病学与生物统计真实世界研究与卫生经济

撒哈拉以南非洲开展的已发表随机试验聚焦高负担疾病,但常由高收入国家资助和主导

Published randomized trials performed in Sub-Saharan Africa focus on high-burden diseases but are frequently funded and led by high-income countries.
PubMed 文献 · J Clin Epidemiol · 2016-11-16

该研究检索PubMed、Cochrane图书馆和African Index Medicus,纳入2014年1月1日至2015年3月31日发表的121项在撒哈拉以南非洲开展的随机对照试验。结果显示,109项试验(90%)的试验中心仅位于撒哈拉以南非洲,其中44/109项(40%)通讯作者唯一隶属机构在撒哈拉以南非洲,77/109项(70%)为非营利资助且81%(63/77)来自高收入国家;多数试验针对撒哈拉以南非洲高负担疾病,但负担最高的25种疾病或健康状况中有9种(36%)未在任何试验中评估。

要点

  • 121项试验中109项(90%)试验中心仅位于撒哈拉以南非洲,44/109项(40%)通讯作者唯一隶属机构在撒哈拉以南非洲。
  • 77/109项(70%)试验为非营利资助,其中81%(63/77)来自高收入国家。
  • 负担最高的25种疾病或健康状况中有9种(36%)未在任何随机对照试验中评估。

核心结论

  • 在撒哈拉以南非洲开展的已发表随机对照试验主要由高收入国家机构资助和主导,尽管研究关注的是撒哈拉以南非洲高流行疾病。

研究设计与样本

  • 研究检索PubMed、Cochrane图书馆和African Index Medicus,纳入2014年1月1日至2015年3月31日发表的在撒哈拉以南非洲开展的所有随机对照试验报告,共121项。

主要发现

  • 121项随机对照试验中仅12项同时在撒哈拉以南非洲和另一地区开展,109/121项(90%)试验中心仅位于撒哈拉以南非洲。
  • 44/109项试验(40%)通讯作者唯一隶属机构在撒哈拉以南非洲,近半数试验通讯作者隶属机构在高收入国家。
  • 77/109项试验(70%)为非营利资助,其中81%(63/77)来自高收入国家。
  • 46%的试验针对撒哈拉以南非洲负担最高的五种疾病,主要为疟疾(n=25)、HIV/AIDS(n=24)、下呼吸道感染(n=2)、腹泻病(n=3)和早产并发症(n=2)。
  • 撒哈拉以南非洲负担最高的25种疾病或健康状况中,9种(36%)未在任何随机对照试验中评估。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: In light of funding constraints in Sub-Saharan Africa (SSA), the value of research performed there must be increased. The objective of this study was to describe the epidemiology of published randomized controlled trials (RCTs) performed in SSA. METHODS: We searched PubMed, the Cochrane library, and African Index Medicus to identify reports of all RCTs performed in SSA and published between January 1, 2014 and March 31, 2015. We systematically recorded the country of the affiliation of the corresponding author and the funding source. The overall burden of disease was assessed by 2013 disability-adjusted life years (both sexes, all ages) in percentages for two locations: SSA and high-income countries (HICs). RESULTS: Only 12 of 121 RCTs were conducted in both Sub-Saharan Africa and another region, with 109 of 121 RCTs (90%) having trial centers exclusively located in SSA. The corresponding author's only affiliation was in SSA for 44/109 trials (40%) and was institutions in HICs for almost half of the trials. The funding source was nonprofit for 77/109 trials (70%) and was from HICs for 81% (n = 63/77). Overall, most RCTs targeted diseases with a high burden in SSA; 46% of the trials targeted the five diseases with the highest burden in SSA, mainly malaria (n = 25), HIV/AIDS (n = 24), lower respiratory tract infection (n = 2), diarrheal diseases (n = 3), and preterm birth complications (n = 2). Nevertheless, among the 25 diseases or health-related conditions with the highest burden in SSA, 9 (36%) were not assessed in any RCT. CONCLUSIONS: Published RCTs performed in SSA were mainly funded and led by HIC institutions, although investigations concerned diseases highly prevalent in SSA.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Ndounga Diakou LA, Ntoumi F, Ravaud P, et al. Published randomized trials performed in Sub-Saharan Africa focus on high-burden diseases but are frequently funded and led by high-income countries. J Clin Epidemiol. 2016. PMID: 27865901. doi:10.1016/j.jclinepi.2016.10.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。